A Multicenter Study Comparing the Efficacy, Safety and Tolerability of Oral Dydrogesterone 30 mg Daily Versus Intravaginal Micronized Progesterone Capsules 600 mg Daily for Luteal Support in In-Vitro Fertilization

NCT01850030 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1070

Enrollment

INDUSTRY

Sponsor class

Conditions

Female Infertility

Interventions

DRUG: Dydrogesterone 30 mg
DRUG: Micronized Progesterone 600 mg
DRUG: Placebo progesterone
DRUG: Placebo dydrogesterone

Sponsor

Abbott

Collaborators

[object Object]